Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125209271 | 12520927 | 1 | I | 20151120 | 20160620 | 20160701 | 20160701 | EXP | GB-MHRA-ADR 23512110 | GB-DRREDDYS-GER/UKI/16/0080849 | DR REDDYS | 51.00 | YR | F | Y | 62.00000 | KG | 20160701 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125209271 | 12520927 | 1 | PS | Atorvastatin | ATORVASTATIN | 1 | Oral | U | UNKNOWN | 91650 | 10 | MG | TABLET | ||||||
| 125209271 | 12520927 | 2 | SS | Atorvastatin | ATORVASTATIN | 1 | Oral | U | UNKNOWN | 91650 | 40 | MG | TABLET | ||||||
| 125209271 | 12520927 | 3 | C | KEPPRA | LEVETIRACETAM | 1 | 0 | 4000 | MG | ||||||||||
| 125209271 | 12520927 | 4 | C | FRISIUM | CLOBAZAM | 1 | AS NECESSARY | 0 | |||||||||||
| 125209271 | 12520927 | 5 | C | TEGRETOL XR | CARBAMAZEPINE | 1 | 0 | 1400 | MG | ||||||||||
| 125209271 | 12520927 | 6 | C | LEVETIRACETAM. | LEVETIRACETAM | 1 | 0 | 1000 | MG | QID | |||||||||
| 125209271 | 12520927 | 7 | C | ZONISAMIDE. | ZONISAMIDE | 1 | 200MG MORNING, 100MG MIDDAY, 200MG NOCTE | 0 | 500 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125209271 | 12520927 | 1 | Product used for unknown indication |
| 125209271 | 12520927 | 3 | Product used for unknown indication |
| 125209271 | 12520927 | 4 | Product used for unknown indication |
| 125209271 | 12520927 | 5 | Product used for unknown indication |
| 125209271 | 12520927 | 6 | Product used for unknown indication |
| 125209271 | 12520927 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125209271 | 12520927 | DS |
| 125209271 | 12520927 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125209271 | 12520927 | Amnesia | |
| 125209271 | 12520927 | Asthenia | |
| 125209271 | 12520927 | Balance disorder | |
| 125209271 | 12520927 | Change in seizure presentation | |
| 125209271 | 12520927 | Dizziness | |
| 125209271 | 12520927 | Epilepsy | |
| 125209271 | 12520927 | Fatigue | |
| 125209271 | 12520927 | Influenza like illness | |
| 125209271 | 12520927 | Muscle rigidity | |
| 125209271 | 12520927 | Muscular weakness | |
| 125209271 | 12520927 | Nasopharyngitis | |
| 125209271 | 12520927 | Paralysis | |
| 125209271 | 12520927 | Speech disorder | |
| 125209271 | 12520927 | Syncope | |
| 125209271 | 12520927 | Tonic clonic movements | |
| 125209271 | 12520927 | Vision blurred | |
| 125209271 | 12520927 | Visual impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125209271 | 12520927 | 1 | 20151120 | 0 | ||
| 125209271 | 12520927 | 2 | 20160503 | 0 |